Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01117116 · ClinicalTrials.gov registry record · NA
Sub-Sensitivity to Long-Acting Bronchodilators (LABA)
A NA study, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01117116 is a NA study that has completed, run by National Jewish Health. The registered enrollment target is 20 participants.
The verdict
NCT01117116, a NA study, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to look at whether Advair® and SYMBICORT® have different effects on airway constriction by means of methacholine challenge testing.
Interventions
- DRUG fluticasone propionate and salmeterol
- DRUG budesonide and formoterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-03 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01117116
The ClinicalTrials.gov registry entry for NCT01117116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which fluticasone propionate and salmeterol is the first listed.
NCT01117116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01117116 about?
NCT01117116 is a clinical study titled "Sub-Sensitivity to Long-Acting Bronchodilators (LABA)". The purpose of this study is to look at whether Advair® and SYMBICORT® have different effects on airway constriction by means of methacholine challenge testing.
What is the current status of trial NCT01117116?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-03. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01117116?
The interventions under investigation include: fluticasone propionate and salmeterol (DRUG), budesonide and formoterol (DRUG).
Who is sponsoring clinical trial NCT01117116?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.